Searched for
GLAXOSMITHKLINE CONSUMER HEALTHCARE
These large-caps have ‘strong buy’ & ‘buy’ recos and an upside potential of up to 26%Just look at developments in the past 48 hours. The war between Iran and Israel resumed, but within hours Tehran said it had halted all off...
More macro headwinds on the cards? Tackle them with core principles: 6 pharma stocks with upside potential of up to 28%There was a time when the Indian pharma story in the US was almost entirely about inspection risk. The US FDA would inspect a plant, a warn...
Stock picks of the week: 5 stocks with consistent score improvement and upside potential of up to 22%As the market grappled with confusion over the Strait of Hormuz, there was more trouble for the bulls. After a few days of respite, another...
Long-term Investing: Ecosystem with an edge called India; 12 large- mid- and small-cap stocks with upside potential of up to 34%Tactical investing should not be confused with long-term investing. In a world where geopolitical risk, commodity shocks, and uncertainty a...
These large-caps have ‘strong buy’ & ‘buy’ recos and an upside potential of up to 25%Here’s a thing investors in equity need to keep in mind. A large part of the upmove one might see in the next one or two trading sessions w...
These large-caps have ‘strong buy’ & ‘buy’ recos and an upside potential of up to 25%It is tough to think positively about the markets when all the news is about blockades, wars, and everything that can disturb the global ec...
GSK Consumer Q2 profit up 4.73% at Rs 192 croreRevenue from operations was at Rs 1,115.32 crore. It was at Rs 1,192.76 crore in the year-ago period.
GlaxoSmithKline consumer healthcare Q4 up 8.4% to Rs 176 croreTotal income from operations was Rs 1208.76 crore in Q4, up from Rs 1192.22 crore in the corresponding period last fiscal, a company statem...
- Buy GlaxoSmithKline Consumer Healthcare., target Rs 7500: Bank of America Merrill Lynch
BofA-ML expects a cyclical upturn in FY2016-19 after poor revenue growth in FY2016.
Hit by strike, GSK Consumer suspends ops at Punjab plantThe company added that it took the step "in the interest of safety and security of its employees and to protect the assets of the factory".
- Buy GlaxosmithKline Consumer Healthcare with a target of Rs 6,430: Sandeep Wagle
"GlaxosmithKline Consumer Healthcare is a 'BUY' call with a target of Rs 6,430 and a stop loss of Rs 6,070. "
GlaxoSmithKline Consumer Healthcare Ltd India-Novartis deal won't affect business in IndiaGlaxoSmithKline Consumer Healthcare today said the global deal between GlaxoSmithKline Plc and Novartis won't affect its business in India.
GlaxoSmithKline Consumer expands Horlicks portfolioHorlicks Kesar Badaam is the fourth variant in the Horlicks portfolio; the other flavours available are Malt, Chocolate and Elaichi.
- GlaxoSmithkline Consumer Q4 net profit up 18% at Rs 70 crore
GlaxoSmithkline Consumer Healthcare today reported 17.85 per cent rise in net profit at Rs 69.65 crore for the fourth quarter ended Decembe...
- GlaxoSmithKline Plc's open offer for GSKCH to start on January 17
The UK-based GlaxoSmithKline Plc's open offer to acquire 31.8 per cent stake in its Indian subsidiary GlaxoSmithKline Consumer Healthcare w...
GSK to raise stake in GlaxoSmithKline Consumer Healthcare via open offerGlaxoSmithKline plans to raise its stake in its Indian consumer products arm to 75 per cent from 43.16 per cent through an open offer.
- GSK Consumer hits record high on parent company's plan to raise its stake
GSK Consumer surged 20% to hit its record high in early trade after its parent plans to raise its stake in Indian arm to 75%.
- GlaxoSmithkline Consumer Q3 net up 25 pc at Rs 128.55 cr
GlaxoSmithkline Consumer Healthcare Ltd today reported 24.76 per cent jump in net profit at Rs 128.55 crore for the third quarter ended Sep...
- India, China new profit centres for GSK Consumer
Glaxosmithkline Consumer Healthcare has elevated India and China into separate profit centres that will report directly to its headquarters...
- GSK Consumer Healthcare net up 30 pc at Rs 71.75 cr
GlaxoSmithKline Consumer Healthcare Ltd reported a 30 per cent jump in net profit for the quarter ended June 30, 2010 at Rs 71.75 crore fro...